Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ardern-Jones

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
European Journal of Cancer Care|June 15, 2005
Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40A Ardern-Jones, R Kenen, R Eeles
Social Science & Medicine (1982)|May 18, 2004
Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancerN Hallowell, C Foster, R Eeles, et al.
Journal of Medical Ethics|April 4, 2003
Balancing autonomy and responsibility: the ethics of generating and disclosing genetic informationN Hallowell, C Foster, R Eeles, et al.
Genetic Testing|September 7, 2002
Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searchingN Hallowell, C Foster, A Ardern-Jones, et al.
Familial Cancer|October 24, 2003
A paradox: urgent BRCA genetic testingG Mitchell, A Ardern-Jones, M Kissin Mchir, et al.
Journal of Genetic Counseling|June 17, 2005
Men's decision-making about predictive BRCA1/2 testing: the role of familyN Hallowell, A Ardern-Jones, R Eeles, et al.
Journal of Genetic Counseling|May 12, 2007
Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relativesE Ormondroyd, C Moynihan, M Watson, et al.
Clinical Genetics|April 29, 2005
Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problemsN Hallowell, A Ardern-Jones, R Eeles, et al.
Psycho-Oncology|August 9, 2008
Communicating genetics research results to families: problems arising when the patient participant is deceasedE Ormondroyd, C Moynihan, A Ardern-Jones, et al.
Psycho-Oncology|August 17, 2017
Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancerC Moynihan, E K Bancroft, A Mitra, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
European Journal of Cancer Care|June 15, 2005
Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40A Ardern-Jones, R Kenen, R Eeles
Social Science & Medicine (1982)|May 18, 2004
Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancerN Hallowell, C Foster, R Eeles, et al.
Journal of Medical Ethics|April 4, 2003
Balancing autonomy and responsibility: the ethics of generating and disclosing genetic informationN Hallowell, C Foster, R Eeles, et al.
Genetic Testing|September 7, 2002
Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searchingN Hallowell, C Foster, A Ardern-Jones, et al.
Familial Cancer|October 24, 2003
A paradox: urgent BRCA genetic testingG Mitchell, A Ardern-Jones, M Kissin Mchir, et al.
Journal of Genetic Counseling|June 17, 2005
Men's decision-making about predictive BRCA1/2 testing: the role of familyN Hallowell, A Ardern-Jones, R Eeles, et al.
Journal of Genetic Counseling|May 12, 2007
Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relativesE Ormondroyd, C Moynihan, M Watson, et al.
Clinical Genetics|April 29, 2005
Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problemsN Hallowell, A Ardern-Jones, R Eeles, et al.
Psycho-Oncology|August 9, 2008
Communicating genetics research results to families: problems arising when the patient participant is deceasedE Ormondroyd, C Moynihan, A Ardern-Jones, et al.
Psycho-Oncology|August 17, 2017
Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancerC Moynihan, E K Bancroft, A Mitra, et al.
Pageof 3